(HealthDay)—The U.S. Food and Drug Administration on Friday approved the emergency use of a smaller dose of Pfizer’s coronavirus vaccine
Continue reading »
Home »
FDA approves immunotherapy for dMMR endometrial cancer
The anti-programmed death receptor 1 (PD-1) monotherapy Jemperli (dostarlimab) received approval for treatment of mismatch repair-deficient (dMMR) recurrent or advanced
Continue reading »
FDA approves 1st long-acting HIV drug combo, monthly shots
Doctors may have cured second man of HIV Doctors in London performed a bone marrow transplant on the patient and
Continue reading »
FDA Approves Expanded Indication for Merck’s Keytruda (pembrolizumab) in Adult Patients With Relapsed or Refractory Classical Hodgkin Lymphoma (cHL)
KENILWORTH, N.J.–(BUSINESS WIRE) October 15, 2020 — Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced
Continue reading »
FDA approves first noninjection glucagon therapy
(HealthDay)—The U.S. Food and Drug Administration has approved the first noninjection glucagon therapy for emergency treatment of severe hypoglycemia, the
Continue reading »
FDA Approves Duobrii
LAVAL, Quebec, April 25, 2019 /PRNewswire/ — Bausch Health Companies Inc. (NYSE/TSX: BHC) and its dermatology business, Ortho Dermatologics, one
Continue reading »
FDA Approves Skyrizi
NORTH CHICAGO, Ill., April 23, 2019 /PRNewswire/ — AbbVie today announced that the U.S. Food and Drug Administration (FDA) approved
Continue reading »
FDA Approves First Advair HFA Generic for Asthma and COPD
After years of patent disputes over the blockbuster inhaler, Advair, a new generic, manufactured by Mylan, will be available in
Continue reading »
FDA approves firdapse for rare autoimmune disorder
(HealthDay)—Firdapse (amifampridine) tablets have been approved by the U.S. Food and Drug Administration for adults with Lambert-Eaton myasthenic syndrome (LEMS).
Continue reading »
US approves first new type of flu drug in 2 decades
U.S. health regulators have approved the first new type of flu drug in two decades. Wednesday’s approval of Xofluza for
Continue reading »